Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipepidine as adjuvant therapy in major depression
IRCT20090117001556N122Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tipepidine hibenzate in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
tipepidine hibenzate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20090117001556N122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N122.